Traws Pharma (TRAW) Revenue (2012 - 2025)
Traws Pharma (TRAW) posted quarterly Revenue of $2.7 million for Q2 2025, up 4694.74% year-over-year from $57000.0 in Q2 2024, and up 4694.74% quarter-over-quarter from $57000.0 in Q1 2025.
Traws Pharma (TRAW) Revenue (2012 - 2025) Analysis & Trends
Traws Pharma (TRAW) has reported Revenue for 14 consecutive years, with $2.7 million the latest figure, recorded in Q2 2025.
- In Q2 2025, Revenue rose 4694.74% year-over-year to $2.7 million; the TTM figure through Dec 2025 stood at $2.8 million (up 1134.51% YoY), while the FY2025 annual figure was $2.8 million, up 1134.51% from the prior year.
- Revenue climbed to $2.7 million in Q2 2025 per TRAW's latest filing, from $57000.0 in the prior quarter.
- Across five years, Revenue topped out at $2.7 million in Q2 2025 and bottomed at $56000.0 in Q1 2021.
- Historically, Revenue has averaged $205222.2 across 5 years, with a median of $57000.0 in 2021.
- Annual changes were most pronounced in 2021 — Revenue dropped 13.64% — and 2025, when it surged 4694.74%.
- Traws Pharma's Revenue stood at $56000.0 in 2021, then changed by 0.0% to $56000.0 in 2022, then changed by 0.0% to $56000.0 in 2023, then changed by 0.0% to $56000.0 in 2024, then soared by 4780.36% to $2.7 million in 2025.
- Business Quant data shows TRAW's Revenue at $2.7 million in Q2 2025, $57000.0 in Q1 2025, and $56000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Traws Pharma | 5.60 Mn | 588,417.40 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.73 Mn |
| Mar 31, 2025 | 57,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 57,000.00 |
| Mar 31, 2024 | 56,000.00 |
| Dec 31, 2023 | 56,000.00 |
| Sep 30, 2023 | 57,000.00 |
| Jun 30, 2023 | 57,000.00 |
| Mar 31, 2023 | 56,000.00 |
| Dec 31, 2022 | 56,000.00 |
| Sep 30, 2022 | 57,000.00 |
| Jun 30, 2022 | 57,000.00 |
| Mar 31, 2022 | 56,000.00 |
| Dec 31, 2021 | 56,000.00 |
| Sep 30, 2021 | 57,000.00 |
| Jun 30, 2021 | 57,000.00 |
| Mar 31, 2021 | 56,000.00 |
| Dec 31, 2020 | 57,000.00 |
| Sep 30, 2020 | 66,000.00 |